Carmot Therapeutics scores $15 mln
Berkeley, California-based Carmot Therapeutics Inc, a biotech company, has secured $15 million in financing. Horizons Ventures and The Column Group led the round. In addition to the funding, Patrick Zhang of Horizons Ventures has become a board observer while Dr. Adriana Tajonar from The Column Group was added to the board of directors.
18 January 2018•1 min read
